About Us
Developing safer,
non-opioid analgesics with clear clinical differentiation
South Rampart Pharma, Inc. is a clinical-stage biopharmaceutical company developing novel, non-opioid, non-NSAID small molecules for the treatment of pain. Our lead asset, SRP-001, is designed to overcome key limitations of current analgesics—including liver and kidney toxicity, gastrointestinal effects, and addiction potential.
Let's get in touch
